Article Text

other Versions

PDF
A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1
  1. Luc Laberge (luc_laberge{at}uqac.ca)
  1. Département des sciences de l'éducation et de psychologie, Université du Québec à Chicoutimi, Canada
    1. Paul Bégin (paul.begin{at}usherbrooke.ca)
    1. Centre de santé et de services sociaux de Chicoutimi, Canada
      1. Yves Dauvilliers (ydauvilliers{at}yahoo.fr)
      1. Gui de Chauliac Hospital, France
        1. Michel Beaudry (michel.beaudry{at}videotron.ca)
        1. Centre de santé et de services sociaux de Chicoutimi, Canada
          1. Mario Laforte (laforte.mario{at}videotron.ca)
          1. Centre de santé et de services sociaux de Chicoutimi, Canada
            1. Stéphane Jean (stephane_jean{at}uqac.ca)
            1. Centre de santé et de services sociaux de Jonquière, Canada
              1. Jean Mathieu (jmathieu{at}saglac.qc.ca)
              1. Centre de santé et de services sociaux de Jonquière, Canada

                Abstract

                Objectives: To assess contributors to excessive daytime sleepiness (EDS) in myotonic dystrophy type 1 (DM1), to characterize subjects with sleep-onset REM periods (SOREMPs), and to verify whether self-reported instruments and respiratory function tests can predict multiple sleep latency test (MSLT) and sleep-disordered breathing.

                Methods: A sample of 43 DM1 patients without selection bias underwent polysomnography (PSG) for two consecutive nights and MSLT, completed a sleep diary and Epworth Sleepiness Scale (ESS), and were assessed for respiratory function and narcolepsy symptoms.

                Results: ESS scores (ES) ≥11 and MSLT mean sleep latency (MSL) ≤8 min were found in 21 (50.0%) and 19 (44.2%) subjects, and either in 30 (69.8%) subjects. ES did not relate to MSL. Subjects with subjective sleepiness (ES≥11) reported more cataplexy-like and sleep paralysis symptoms, longer habitual sleep times, and higher sleep efficiency and REM sleep percent than those without. Subjects with objective sleepiness (MSL≤8 min) had higher stage 4 sleep percent. Subjects with ≥2 SOREMPs (25.6%) showed higher muscular impairment, lower MSL, higher ES, and more cataplexy-like symptoms than those with ≤1 SOREMP. Apnea-hypopnea index (AHI) >5, predominantly obstructive, was found in 37 (86.0%) subjects, and AHI >30 in 12 (27.9%). Neither subjective nor objective sleepiness could be explained by AHI, nor satisfactorily predicted by daytime respiratory abnormalities.

                Conclusions: DM1 entails frequent EDS but with different phenotypes and distinct mechanisms involved. The high prevalence of daytime sleepiness and severe sleep apneas found in this study supports the routine use of clinical sleep interviews, PSG, and MSLT in DM1 and emphasizes the need for more randomized trials of psychostimulants.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.